Shares of SR MEDICAL (00108) surged more than 12% in early trading on the Hong Kong stock exchange. At the time of writing, the stock was up 9.18% at HK$2.20 with a turnover of HK$1.61 million.

According to the company's interim financial report for the first half of 2026, SR MEDICAL recorded total revenue of HK$223 million, representing a year-on-year increase of approximately 30.7%. The company's intelligent medical services segment generated HK$65.58 million in revenue, while the property investment and operations management segment contributed HK$158 million.

Notably, the intelligent medical services business posted a profit of HK$12.77 million during the first half of the year. According to public information, in December last year, Guorui Group's Hong Kong-listed arm, Guorui Living, acquired a 78.3% stake in Chunyu Doctor for RMB 269 million. In July this year, Guorui Living was officially renamed SR MEDICAL following the completion of the acquisition.

With the official launch of "SR Medical Technology," the Guorui Group plans to deeply integrate its industrial technology and asset management divisions, extending Chunyu Doctor's digital medical services across a broader range of properties, communities, and urban areas.